Aspira improves on inhaler dispensing

Breath-actuated inhalers are activated automatically when the user inhales. This automatic release makes it easier for patients such as children or the elderly, who have trouble co-ordinating conventional press-and-breathe inhalers.

The inhaler also has an integrated dose-counter, already used in B&O Mediacom’s asthma inhaler range. It can record up to 200 individual doses and is a useful feature for users who have difficulty tracking their medication.

“Aspira is a cost-effective solution for the treatment of diabetes, due to a reservoir technology which reduces the daily cost of administering the treatment,” said Christian Husegaard, head of sales and marketing at B&O Medicom.

Insulin inhalers are a recent advancement for diabetic sufferers who have a needle phobia or who do not like taking the injectable form of insulin. 

Popular Articles